杭州高新(300478.SZ):選舉胡寶泉為公司董事長、葉峯為副董事長
格隆匯6月28日丨杭州高新(300478.SZ)公佈,公司於2021年6月28日召開第四屆董事會第六次會議,會議審議通過了《關於選舉公司第四屆董事會董事長和副董事長的議案》,根據《公司法》、《深圳證券交易所創業板上市公司規範運作指引》等法律法規和《公司章程》的規定,以及為進一步推進公司戰略發展,同時完善公司董事會治理,保證公司董事會的運作及決策合法有效,選舉胡寶泉為公司董事長、葉峯為公司副董事長,任期自董事會會議審議通過之日起至第四屆董事會屆滿之日止。
根據《公司法》、《公司章程》的相關規定,公司董事長為公司的法定代表人,因此公司法定代表人同時變更為胡寶泉,公司將提交工商登記變更相關手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.